The DOI matches its Crossref record; 453 of the 453 references it cites were found in a registry or an index.
Bone Turnover Markers: Basic Biology to Clinical Applications
Open accessAbstract
Bone turnover markers (BTMs) are used widely, in both research and clinical practice. In the last 20 years, much experience has been gained in measurement and interpretation of these markers, which include commonly used bone formation markers (bone alkaline phosphatase, osteocalcin, and procollagen I N-propeptide); and commonly used resorption markers (serum C-telopeptides of type I collagen, urinary N-telopeptides of type I collagen, and tartrate-resistant acid phosphatase type 5b). BTMs are usually measured by enzyme-linked immunosorbent assay or automated immunoassay. Sources contributing to BTM variability include uncontrollable factors (eg, age, gender, ethnicity) and controllable factors, particularly relating to collection conditions (eg, fasting/feeding state, and timing relative to circadian rhythms, menstrual cycling, and exercise). Pregnancy, season, drugs, and recent fracture(s) can also affect BTMs. BTMs correlate with other methods of assessing bone turnover, such as bone biopsies and radiotracer kinetics, and can usefully contribute to diagnosis and management of several diseases such as osteoporosis, osteomalacia, Paget’s disease, fibrous dysplasia, hypophosphatasia, primary hyperparathyroidism, and chronic kidney disease–mineral bone disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–453 of 453
Swanson, C. M., Kohrt, W. M., Wolfe, P., Wright, K. P., Shea, S. A., Cain, S. W., Münch, M. Y., Vujović, N., Czeisler, C. A., ORWOLL, E. S., et al. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05135-y · Cited by 33
Peris, P., Torra, M., Olivares, V., Reyes, R., Monegal, A., Martinez-Ferrer, A., & Guañabens, N. (2011) · Bone · doi:10.1016/j.bone.2011.06.027 · Cited by 32
Biochemical bone turnover markers in hormonal disorders in adults: a narrative review
Szulc, P. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01269-7 · Cited by 32
Nowson, C. A., Patchett, A., & Wattanapenpaiboon, N. (2009) · British Journal Of Nutrition · doi:10.1017/s0007114509371731 · Cited by 31
Garnero, P., & Delmas, P. D. (1997) · Baillière s Clinical Rheumatology · doi:10.1016/s0950-3579(97)80018-0 · Cited by 31
Serum Galactosyl Hydroxylysine as a Biochemical Marker of Bone Resorption
Al-Dehaimi, A., Blumsohn, A., & Eastell, R. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.5.676 · Cited by 31
Self-citationEffect of risedronate on bone loss at discontinuation of denosumab
Laroche, M., Couture, G., Ruyssen‐Witrand, A., Constantin, A., & Degboé, Y. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100290 · Cited by 31
Kageyama, Y., Masaaki, T., Nagafusa, T., Hayato, K., & Nagano, A. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0870-8 · Cited by 30
Oikawa, M., Kushida, K., Masaaki, T., Ohishi, T., Hoshino, H., Suzuki, M., Ogihara, H., ISHIGAKI, J., & Inoue, T. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00626.x · Cited by 29
Effects of calcium-fortified ice cream on markers of bone health
Ferrar, L., van der Hee, R. M., Berry, M. J., Watson, C., Miret, S., Wilkinson, J., Bradburn, M. J., & Eastell, R. (2010) · Osteoporosis International · doi:10.1007/s00198-010-1513-x · Cited by 29
Self-citationYamamoto, T., Tsujimoto, M., Hamaya, E., & Sowa, H. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0403-z · Cited by 29
Common bone turnover markers in rheumatoid arthritis and ankylosing spondylitis: A literature review
Coiffier, G., Bouvard, B., Chopin, F., Biver, E., Funck‐Brentano, T., Garnero, P., & Guggenbuhl, P. (2012) · Joint Bone Spine · doi:10.1016/j.jbspin.2012.08.004 · Cited by 29
Lumachi, F., Basso, S. M. M., Camozzi, V., Tozzoli, R., Spaziante, R., & Ermani, M. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.07.005 · Cited by 29
Hadji, P., Gamerdinger, D., Spieler, W., Kann, P. H., Loeffler, H., Articus, K., Moericke, R., & Ziller, V. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1583-4 · Cited by 28
Hormonal determinants of bone turnover before and after attainment of peak bone mass
Walsh, J., Henry, Y. M., Fatayerji, D., & Eastell, R. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03606.x · Cited by 27
Self-citationRegulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
Thiele, S., Hannemann, A., Winzer, M., Baschant, U., Weidner, H., Nauck, M. A., Thakker, R. V., Bornhäuser, M., Hofbauer, L. C., & Rauner, M. (2019) · Endocrine Connections · doi:10.1530/ec-19-0104 · Cited by 26
Comparison of results from commercial assays for plasma CTX: The need for harmonization
Chubb, S. A. P., Mandelt, C., & Vasikaran, S. D. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.03.002 · Cited by 25
Tuck, S. P., & Walker, J. (2020) · Clinical Medicine · doi:10.7861/clinmed.20.6.page · Cited by 25
Neville, C. E., Young, I. S., Gilchrist, S. E. C. M., McKinley, M. C., Gibson, A., Edgar, D., & Woodside, J. V. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2402-x · Cited by 24
Eastell, R., Boonen, S., Cosman, F., Reid, I. R., Palermo, L., Cummings, S. R., & Black, D. M. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2361 · Cited by 23
Self-citationMozzanega, B., Gizzo, S., Bernardi, D., Salmaso, L., Patrelli, T. S., Mioni, R., Finos, L., & Nardelli, G. B. (2013) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-013-0430-4 · Cited by 23
Lei, W., Nguyen, H., Brown, N., Ni, H., Kiffer-Moreira, T., Reese, J., Millán, J. L., & Paria, B. C. (2013) · Reproduction · doi:10.1530/rep-13-0153 · Cited by 23
Bone histomorphometry in transiliac biopsies from 48 normal, healthy men
Recker, R. R., Akhter, M. P., Lappe, J. M., & Watson, P. A. (2018) · Bone · doi:10.1016/j.bone.2018.03.019 · Cited by 23
Bone turnover in hyperthyroidism before and after thyrostatic management
Isaia, G., Roggia, C., Gola, D., Stefano, M. D., Gallone, G., Aimo, G., Ardissone, P., & Mussetta, M. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03345061 · Cited by 22
Rodríguez, E. G., Stoll, D., & Lamy, O. (2018) · Case Reports in Rheumatology · doi:10.1155/2018/5432751 · Cited by 22
Patterns of renal osteodystrophy 1 year after kidney transplantation
Jørgensen, H. S., Behets, G. J. S., Bammens, B., Claes, K. J., Meijers, B. K. I., Naesens, M., Sprangers, B., Kuypers, D. R. J., D’Haese, P. C., & Evenepoel, P. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab239 · Cited by 22
Ursem, S. R., Heijboer, A. C., D’Haese, P. C., Behets, G. J. S., Cavalier, E., Vervloet, M. G., & Evenepoel, P. (2021) · Kidney International · doi:10.1016/j.kint.2020.12.024 · Cited by 21
The clinical utility of TRACP-5b to monitor anti-resorptive treatments of osteoporosis
Gossiel, F., Ugur, A., Peel, N. F. A., Walsh, J., & Eastell, R. (2022) · Osteoporosis International · doi:10.1007/s00198-022-06311-3 · Cited by 20
Self-citationAnalytical validation of serum bone alkaline phosphatase (BAP OSTASE) on Liaison
Cavalier, E., Rozet, E., Carlisi, A., Bekaert, A.-C., Rousselle, O., Hubert, P., Chapelle, J.-P., & Delanaye, P. (2009) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.019 · Cited by 19
Biochemical Response to Bisphosphonate Therapy in Pagetic Patients with Skull Involvement
Peris, P., Álvarez, L., Vidal, S., Kasper, D. C., Leeming, D. J., Monegal, A., Martínez, M. A., Pons, F., & Guañabens, N. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0247-9 · Cited by 19
Ingram, R. T., Collazo–Clavell, M. L., Tiegs, R. D., & Fitzpatrick, L. A. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.5.1810 · Cited by 18
Response of bone turnover markers to raloxifene treatment in postmenopausal women with osteopenia
Naylor, K. E., Jacques, R., Peel, N. F. A., Gossiel, F., & Eastell, R. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3573-z · Cited by 18
Self-citationA microRNA Approach to Discriminate Cortical Low Bone Turnover in Renal Osteodystrophy
Nickolas, T. L., Chen, N. X., McMahon, D. J., Dempster, D. W., Zhou, H., Dominguez, J. M., Aponte, M. A., Sung, J. C., Evenepoel, P., D’Haese, P. C., et al. (2020) · JBMR Plus · doi:10.1002/jbm4.10353 · Cited by 18
Mattia, L., Davis, S., Mark‐Wagstaff, C., Abrahamsen, B., Peel, N. F. A., Eastell, R., & Schini, M. (2022) · Bone · doi:10.1016/j.bone.2022.116347 · Cited by 18
Self-citationKhalil, R., Antonio, L., Laurent, M. R., David, K., Kim, N. R., Evenepoel, P., Eisenhauer, A., Heuser, A., Cavalier, E., Khosla, S., et al. (2020) · European Journal of Endocrinology · doi:10.1530/eje-20-0348 · Cited by 17
Borderie, D., Roux, C., Toussaint, B., Dougados, M., Ekindjian, O. G., & Cherruau, B. (2001) · Clinical Biochemistry · doi:10.1016/s0009-9120(01)00269-7 · Cited by 16
Reference Intervals for Bone Turnover Markers in Korean Healthy Women
Cho, D. H., Chung, J. O., Chung, M. Y., Cho, J.-R., & Chung, D. J. (2020) · Journal of Bone Metabolism · doi:10.11005/jbm.2020.27.1.43 · Cited by 16
Cortet, B., Flipo, R., Pigny, P., Duquesnoy, B., Racadot, A., Boersma, A., & Delcambre, B. (1997) · PubMed · Cited by 15
A comparative study of bone biopsies from the iliac crest, the tibial bone, and the lumbar spine
Hiller, R. G. G., Patecki, M., Neunaber, C., Reifenrath, J., Kielstein, J. T., & Kielstein, H. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0550-5 · Cited by 15
McKenna, M. J., Martin‐Grace, J., Crowley, R. K., Twomey, P. J., & Kilbane, M. T. (2018) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-018-0957-5 · Cited by 15
Influence of the sample matrix on the stability of beta-CTX at room temperature for 24 and 48 hours.
Lippi, G., Brocco, G., Salvagno, G. L., Montagnana, M., Guidi, G. C., & Schmidt‐Gayk, H. (2007) · PubMed · Cited by 12
Wheater, G., Goodrum, C., Tuck, S. P., Datta, H. K., & van Laar, J. M. (2014) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2013-0934 · Cited by 12
Bone turnover markers are differentially affected by pre-analytical handling
Christensen, G. L., Halgreen, J. R., Milenkovski, M., Köse, A., Quardon, N., & Jørgensen, N. R. (2019) · Osteoporosis International · doi:10.1007/s00198-019-04837-7 · Cited by 11
Telopeptides as markers of bone turnover in rheumatoid arthritis and osteoarthritis
Wong, P. K. K., Young, L., Vaile, J. H., Tan, L., Bertouch, J. V., Bleasel, J. F., & White, C. (2004) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2004.00647.x · Cited by 10
Adherence to raloxifene therapy: assessment methods and relationship with efficacy
Finigan, J., Naylor, K. E., Paggiosi, M., Peel, N. F. A., & Eastell, R. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2386-6 · Cited by 10
Self-citationCavalier, E., Lukas, P., & Delanaye, P. (2021) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2021-1190 · Cited by 10
Zürcher, S. J., Borter, N., Kränzlin, M., Neyer, P. J., Meyer, U., Rizzoli, R., & Kriemler, S. (2019) · Osteoporosis International · doi:10.1007/s00198-019-05180-7 · Cited by 9
Mawatari, T., Ikemura, S., Matsui, G., Iguchi, T., Mitsuyasu, H., Kawahara, S., Maehara, M., Muraoka, R., Iwamoto, Y., & Nakashima, Y. (2020) · Bone Reports · doi:10.1016/j.bonr.2020.100275 · Cited by 8
Fassio, A., Adami, G., Idolazzi, L., Giollo, A., Viapiana, O., Vantaggiato, E., Benini, C., Rossini, M., Dejaco, C., & Gatti, D. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00551 · Cited by 8
Aspects of intercellular communication in bone and implications in therapy
Martin, T. J. (2021) · Bone · doi:10.1016/j.bone.2021.116148 · Cited by 8
Dynamic short crack growth in cortical bone
Hazenberg, J. G., Taylor, D. M., & Lee, T. C. (2006) · Technology and Health Care · doi:10.3233/thc-2006-144-520 · Cited by 7
Umarji, P. B., Verma, P., Garg, V., Schini, M., & Eastell, R. (2021) · Nutrients · doi:10.3390/nu13020364 · Cited by 7
Self-citation(2017) · Europe PMC (PubMed Central)
Cited by
Farr, J. N., Atkinson, E. J., Achenbach, S. J., Volkman, T. L., Tweed, A. J., Vos, S. J., Ruan, M., Sfeir, J., Drake, M. T., Saul, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03096-2 · Cited by 127
“…frailty or cognition, which can be difficult to measure, may include subjective features and require large numbers of participants and prolonged interventions, bone turnover markers are simple, objective measures of a biological outcome that respond within only a few weeks to an intervention 15 .”
Metadata
- Authors
- Schini, M., Vilaca, T., Gossiel, F., Salam, S., & Eastell, R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2022-12-13
- Volume
- 44
- Issue
- 3
- Pages
- 417-473
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W4311287698
- Cited by
- 387
- References
- 453
- FWCI
- 59.25
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.